Skip to main content
. Author manuscript; available in PMC: 2015 Jun 18.
Published in final edited form as: Pediatrics. 2013 Apr 22;131(5):e1502–e1508. doi: 10.1542/peds.2012-3435

TABLE 2.

Live Birth Prevalence of CHDs and CCHDs in Metropolitan Atlanta, Georgia: 1979–2005

Period Births Cases per 10 000 Live Births (95% CI)
All CHDs All CCHDs CCHD Primary Targets
1979–1986 228 566 50.1 (47.3–53.1) 17.1 (15.5–18.9) 11.9 (10.5–13.4)
1987–1993 264 060 55.0 (52.3–57.9) 16.4 (14.9–18.0) 11.3 (10.1–12.6)
1994–1999 255 847 68.9 (65.8–72.2) 17.9 (16.4–19.7) 11.3 (10.1–12.7)
2000–2005 308 068 84.5 (81.3–87.8) 17.8 (16.4–19.3) 11.2 (10.1–12.5)
Total 1 056 541 65.9 (64.4–67.5) 17.3 (16.5–18.1) 11.4 (10.8–12.1)

CCHDs include primary targets (hypoplastic left heart syndrome, transposition of the great arteries, tricuspid atresia, truncus arteriosus, tetralogy of Fallot, total anomalous pulmonary venous return, and pulmonary atresia) and secondary targets (interrupted aortic arch, coarctation of the aorta, double outlet right ventricle, Ebstein’s anomaly, and single ventricle) of screening.

HHS Vulnerability Disclosure